Review: cardioselective β1 blockers given for 3 days to 4 weeks do not reduce respiratory function in reactive airway disease

  • Jura, Britt J MD
  • Blanchard, Amy R MD
  • Salpeter, S R
  • Ormiston, T M
  • Salpeter, E E.

  • 1Medical College of Georgia, Augusta, Georgia, USA

    2Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 2002;137:715-25

Source of funding: no external funding.

For correspondence: Dr S Salpeter, Santa Clara Valley Medical Center, San Jose, California, USA.[email protected]

Evidence Based Medicine 8(3):p 73, May 2003.
Copyright © British Medical Journal 2003.